Gill JS - Search Results

1

Global Estimates of Capacity for Kidney Transplantation in World Countries and Regions.

Mudiayi D, Shojai S, Okpechi I, Christie EA, Wen K, Kamaleldin M, Elsadig Osman M, Lunney M, Prasad B, Osman MA, Ye F, Khan M, Htay H, Caskey F, Jindal KK, Klarenback S, Jha V, Rondeau E, Turan Kazancioglu R, Ossareh S, Jager KJ, Kovesdy CP, O'Connell PJ, Muller E, Olanrewaju T, Gill JS, Tonelli M, Harris DC, Levin A, Johnson DW, Bello AK. Mudiayi D, et al. Among authors: gill js. Transplantation. 2022 Jun 1;106(6):1113-1122. doi: 10.1097/TP.0000000000003943. Epub 2022 Sep 7. Transplantation. 2022. PMID: 34495014 Free PMC article.

2

Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency.

Tonelli M, Bohm C, Pandeya S, Gill J, Levin A, Kiberd BA. Tonelli M, et al. Am J Kidney Dis. 2001 Mar;37(3):484-9. Am J Kidney Dis. 2001. PMID: 11228171

3

Slowing the progression of chronic renal insufficiency.

Tonelli M, Gill J, Pandeya S, Bohm C, Levin A, Kiberd BA. Tonelli M, et al. CMAJ. 2002 Apr 2;166(7):906-7. CMAJ. 2002. PMID: 11949987 Free PMC article. No abstract available.

4

Barriers to blood pressure control and angiotensin enzyme inhibitor use in Canadian patients with chronic renal insufficiency.

Tonelli M, Gill J, Pandeya S, Bohm C, Levin A, Kiberd BA. Tonelli M, et al. Nephrol Dial Transplant. 2002 Aug;17(8):1426-33. doi: 10.1093/ndt/17.8.1426. Nephrol Dial Transplant. 2002. PMID: 12147790 Clinical Trial.

5

The change in allograft function among long-term kidney transplant recipients.

Gill JS, Tonelli M, Mix CH, Pereira BJ. Gill JS, et al. J Am Soc Nephrol. 2003 Jun;14(6):1636-42. doi: 10.1097/01.asn.0000070621.06264.86. J Am Soc Nephrol. 2003. PMID: 12761266

6

The effect of maintenance immunosuppression medication on the change in kidney allograft function.

Gill JS, Tonelli M, Mix CH, Johnson N, Pereira BJ. Gill JS, et al. Kidney Int. 2004 Feb;65(2):692-9. doi: 10.1111/j.1523-1755.2004.00431.x. Kidney Int. 2004. PMID: 14717943 Free article.

7

Death and renal transplantation among Aboriginal people undergoing dialysis.

Tonelli M, Hemmelgarn B, Manns B, Pylypchuk G, Bohm C, Yeates K, Gourishankar S, Gill JS. Tonelli M, et al. Among authors: gill js. CMAJ. 2004 Sep 14;171(6):577-82. doi: 10.1503/cmaj.1031859. CMAJ. 2004. PMID: 15367459 Free PMC article.

8

Why do preemptive kidney transplant recipients have an allograft survival advantage?

Gill JS, Tonelli M, Johnson N, Pereira BJ. Gill JS, et al. Transplantation. 2004 Sep 27;78(6):873-9. doi: 10.1097/01.tp.0000130204.80781.68. Transplantation. 2004. PMID: 15385807

9

Use and outcomes of peritoneal dialysis among Aboriginal people in Canada.

Tonelli M, Hemmelgarn B, Manns B, Davison S, Bohm C, Gourishankar S, Pylypchuk G, Yeates K, Gill JS. Tonelli M, et al. Among authors: gill js. J Am Soc Nephrol. 2005 Feb;16(2):482-8. doi: 10.1681/ASN.2004070560. Epub 2004 Dec 8. J Am Soc Nephrol. 2005. PMID: 15590757

10

Cardiovascular events and investigation in patients who are awaiting cadaveric kidney transplantation.

Gill JS, Ma I, Landsberg D, Johnson N, Levin A. Gill JS, et al. J Am Soc Nephrol. 2005 Mar;16(3):808-16. doi: 10.1681/ASN.2004090810. Epub 2005 Feb 2. J Am Soc Nephrol. 2005. PMID: 15689406

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

456 results

Search Page